✦ LIBER ✦

Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group

✍ Scribed by Kudoh, S.; Nakamura, S.; Nakano, T.; Komuta, K.; Isobe, T.; Katakami, N.; Fukuda, Y.; Takada, Y.; Takada, M.; Fukuoka, M.; Ariyoshi, Y.

Book ID: 119319157
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 108 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2005.01.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of fractionated irinote

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer

✍ Sohn, Joo Hyuk; Choi, Hye Jin; Chang, Joon; Kim, Se Kyu; Lee, Chang Geal; Chung, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A phase II trial of cisplatin and irinot

A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

✍ Masahiro Tabata; Katsuyuki Kiura; Niro Okimoto; Yoshihiko Segawa; Tetsu Shinkai; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 262 KB

A phase II trial of intravenous vinorelb

A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a southwest oncology group study

✍ Celestia S. Higano; John J. Crowley; Robert V. Veith; Robert B. Livingston 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 28 KB

P-62 Phase II trial of irinotecan plus c

P-62 Phase II trial of irinotecan plus cisplatin after cisplatin plus etoposide and concurrent thoracic radiotherapy (TRT) in small cell lung cancer (SCLC) patients with limited disease: West Japan Thoracic Oncology Group 9902

✍ Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase II study of irinotecan (CPT-11) co

Phase II study of irinotecan (CPT-11) combined with etoposide (VP-16) for previously untreated extensive stage small cell lung cancer (ES-SCLC)

✍ Kudoh, S; Nakamura, S; Komuta, K; Nakano, T; Fukuoka, M; Ariyoshi, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Cisplatin, Irinotecan, and Bevacizumab f

Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

✍ Ready, N. E.; Dudek, A. Z.; Pang, H. H.; Hodgson, L. D.; Graziano, S. L.; Green, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 127 KB